In furtherance to earlier intimation dated 26th October, 2024, wherein the Company had informed that Lyka Labs and Lyka Exports had jointly filed an application on October 25, 2024, with the Hon'ble National Company Law Tribunal, Ahmedabad Bench (the NCLT), under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, seeking directions for convening meetings of equity shareholders and other stakeholders of the aforesaid companies in connection with the proposed Scheme of Amalgamation, Lyka Labs has informed that, pursuant to the aforesaid joint application, the Hon’ble NCLT has pronounced an order dated 23rd January, 2025 (Order), which Order has been uploaded on the NCLT website. A copy of the said Order is enclosed. As per this Order, the Company shall convene the meetings of the equity shareholders and other stakeholders within the stipulated time frame.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1807.25 |
| Dr. Reddys Lab | 1273.90 |
| Cipla | 1388.80 |
| Zydus Lifesciences | 1104.35 |
| Lupin | 2292.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: